Insider Buying Activity Uncovered - 4 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Breaking: Uncle Sam Must Secure "The Seeds of Technology"]( [Learn more about this mega trend and one company hoping to meet demand.]( --------------------------------------------------------------- March 27, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Energy Storage Trend Ignites Frenzy Over Vanadium Supply]( the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply. [See how investors could benefit from domestic vanadium discoveries.]( --------------------------------------------------------------- [LeMaitre Vascular, Inc.]( Ticker: [LMAT]( Recent Price: $65.90 Average Analyst Price Target: $69.00 (4.70%) Market Cap: $1.47B Role Transaction Description No. of Shares Amount Date Chairman & CEO,Director Informative Buy Non Open Market Buy 10,769 $709,693 2 Days Ago Recent Analyst Action: Suraj Kalia, analyst at Oppenheimer, reiterates coverage on [LeMaitre Vascular, Inc. (LMAT)]( in the Healthcare sector with a Buy rating and a price target of $70 (3 weeks ago). Here are 3rd party ratings for [LMAT](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 35% (87 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Dividend Expert Reveals His Biggest Income Secrets... Free of Charge]( Marc Lichtenfeld –Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package… [Free of charge!]( [Click Here to Get His #1 Dividend Stock… The Safest 9% Dividend in the World… Top Three “Extreme Dividend” Stocks, And Much, Much More]( --------------------------------------------------------------- [Halozyme Therapeutics, Inc.]( Ticker: [HALO]( Recent Price: $40.08 Average Analyst Price Target: $52.00 (29.74%) Market Cap: $5.09B Role Transaction Description No. of Shares Amount Date SVP, CTO Informative Buy Non Open Market Buy 3,247 $130,160 2 Days Ago Recent Analyst Action: Brendan Smith, analyst at TD Cowen, reiterates coverage on [Halozyme Therapeutics, Inc. (HALO)]( in the Healthcare sector with a Buy rating and a price target of $54 (2 weeks ago). Here are 3rd party ratings for [HALO](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 32% (81 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Musk: My new robots could be bigger than Tesla]( No one can deny Elon Musk is a visionary. But has he finally gone too far? [>>See the shocking future of AI here<<]( --------------------------------------------------------------- [Entrada Therapeutics, Inc.]( Ticker: [TRDA]( Recent Price: $13.76 Average Analyst Price Target: $21.00 (52.62%) Market Cap: $460.10M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 8,900 122,808 2 Days Ago Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on [Entrada Therapeutics, Inc. (TRDA)]( in the Healthcare sector with a Buy rating and a price target of $20 (1 week ago). Here are 3rd party ratings for [TRDA](: - TipRanks.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Top 32% (81 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [I Couldn't Air my Biggest A.I. Prediction]( built the indicator that Wall Street uses to find winning stocks. Now he's issuing a new prediction about the A.I. market. [Learn more here.]( --------------------------------------------------------------- [American Electric Power Company, Inc.]( Ticker: [AEP]( Recent Price: $82.48 Average Analyst Price Target: $84.20 (2.09%) Market Cap: $43.40B Role Transaction Description No. of Shares Amount Date EVP Informative Buy Non Open Market Buy 105 $8,803 Yesterday EVP Informative Buy Non Open Market Buy 40 $3,354 Yesterday Executive VP & CFO Informative Buy Non Open Market Buy 152 $12,744 Yesterday EVP Informative Buy Non Open Market Buy 176 $14,756 Yesterday Recent Analyst Action: Ross Fowler, analyst at UBS, reiterates coverage on [American Electric Power Company, Inc. (AEP)]( in the Utilities sector with a Sell rating and a price target of $83 (2 weeks ago). Here are 3rd party ratings for [AEP](: - TipRanks.com: Hold - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 40% (152 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold Is Headed Above $3,000 per Ounce (Here's How to Play It?]( so many strange events happening across the economy (the longest bear market for bonds since the Civil War... unprecedented bank closures... and soaring prices), it's no wonder the richest investors are loading up on gold. But what you might not realize is there's a much better way to profit from rising gold prices – WITHOUT ever touching an ETF, mining stock, or even bullion. [Get the full details here.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com 1519 Mecklenburg Hwy Unit 4 | Mt. Mourne | NC | 28123 | United States | 877 411 9808 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software